ArticleACS omega2026
Unlabeled but Not Unseen: Cytotoxicity Classification of Re(I) Tricarbonyl Complexes via K‑Means Clustering.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prediction of cytotoxicity for metal-based drug candidates remains a significant challenge due to the structural diversity and multifactorial mechanisms of action inherent to transition metal complexes. Here, we present an unsupervised machine learning approach employing K-means clustering to cluster the cytotoxicity of 225 rhenium-(I) tricarbonyl complexes based solely on molecular descriptors. After comprehensive descriptor calculation and reduction, principal component analysis was used to assess chemical space coverage and identify key variables. K-means clustering, applied without prior toxicity labels, successfully partitioned the data set into cytotoxic and noncytotoxic clusters, achieving high concordance with known biological activity and accurately clustering control compounds. Analysis of misclassified cases provided further insight into structural motifs associated with ambiguous toxicity profiles. This work demonstrates that K-means clustering, when integrated with robust descriptor selection and PCA, offers a transparent, efficient, and interpretable framework for early stage toxicity assessment in metal-based drug discovery, particularly when labeled data are limited.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.